Have You Had an Experience With Prenatal Genetic Testing? We’d Like to Hear About It — and See the Bill.

We want to understand more about your interactions with genetic screening providers, such as Progenity, Natera, Harmony and others.

by Adriana Gallardo, Anna Clark and Mariam Elba

May 18, 2021, 8 a.m. EDT

Elective genetic screenings before and during pregnancy are safer and more available than ever.

Tests, known as noninvasive prenatal tests, or NIPTs, involve a draw of the expectant parent’s blood. Other tests, called carrier tests, are done before a person gets pregnant to screen for genetic abnormalities. Some common NIPT companies include Progenity, Natera and Harmony. Providers promise to predict the risk for chromosomal abnormalities, without risk to the fetus.

These tests can also be very expensive.

A number of expectant and new mothers have suggested that we look into the effectiveness, cost and transparency of these tests. We want to understand more about the billing process and communication following positive test results. If you have taken or given one of these tests, either as an expectant parent or a provider who works in maternal health, please fill out the brief questionnaire below.

Latest Stories from ProPublica

Republish This Story for Free

Creative Commons License (CC BY-NC-ND 3.0)

Thank you for your interest in republishing this story. You are are free to republish it so long as you do the following:

You have to credit ProPublica and any co-reporting partners. In the byline, we prefer “Author Name, Publication(s).” At the top of the text of your story, include a line that reads: “This story was originally published by ProPublica.” You must link the word “ProPublica” to the original URL of the story.
If you’re republishing online, you must link to the URL of this story on propublica.org, include all of the links from our story, including our newsletter sign up language and link, and use our PixelPing tag.
If you use canonical metadata, please use the ProPublica URL. For more information about canonical metadata, refer to this Google SEO link.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
You cannot republish our photographs or illustrations without specific permission. Please contact [email protected].
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories. You can’t state or imply that donations to your organization support ProPublica’s work.
You can’t sell our material separately or syndicate it. This includes publishing or syndicating our work on platforms or apps such as Apple News, Google News, etc.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. (To inquire about syndication or licensing opportunities, contact [email protected].)
You can’t use our work to populate a website designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
We do not generally permit translation of our stories into another language.
Any website our stories appear on must include a prominent and effective way to contact you.
If you share republished stories on social media, we’d appreciate being tagged in your posts. We have official accounts for ProPublica on Twitter, Facebook and Instagram.

Copy and paste the following into your page to republish:

Current site Current page

Have You Had an Experience With Prenatal Genetic Testing? We’d Like to Hear About It — and See the Bill.

We want to understand more about your interactions with genetic screening providers, such as Progenity, Natera, Harmony and others.

Latest Stories from ProPublica

Biden Asked Microsoft to “Raise the Bar on Cybersecurity.” He May Have Helped Create an Illegal Monopoly.

Senator Slams Gun Industry’s “Invasive and Dangerous” Sharing of Customer Data With Political Operatives

State Regulators Know Health Insurance Directories Are Full of Wrong Information. They’re Doing Little to Fix It.

Meet ProPublica’s 2024 Class of Emerging Reporters